Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 0904-6363

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0904-6363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

49bf56b6 A134 2d0d C783 0cb83b8d1b38 00

The label for Divalproex Sodium 250 mg extended-release, film-coated oral tablets by Major Pharmaceuticals. It is a unit dose, once-daily prescription medication with NDC 0904-6363-61. The package contains 100 tablets, with instructions for pharmacists to dispense with a medication guide. The label provides storage instructions, dosing details, and manufacturer information including Dr. Reddy's Laboratories Limited.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing the percentage reduction in CPS Rate between patients treated with Divalproex Sodium delayed-release tablets and those given a placebo. The x-axis represents the percentage of patients, while the y-axis shows the percent reduction in CPS Rate ranging from -100% to 100%, with labels indicating improvement and worsening.*

FDA Label Image

Figure2 (Figure2)

A cumulative response curve chart showing percentage reduction in clinical parameter scale (CPS) rate versus percentage of patients for Divalproex Sodium delayed-release tablets in high and low doses. The vertical axis indicates improvement or worsening in CPS rate, while the horizontal axis represents the percentage of patients. Two curves compare high dose (solid line) and low dose (dashed line) Divalproex Sodium extended-release tablets.*

FDA Label Image

Figure3 (Figure3)

A bar chart comparing values between placebo and Divalproex Sodium Extended-Release Tablets. The placebo bar is unfilled with a height of 0.6, while the filled black bar for Divalproex Sodium Extended-Release Tablets is taller, reaching 1.2. The x-axis groups the two categories, and the y-axis shows numerical values up to 1.2.*

FDA Label Image

Structure (Structure)

Chemical structure of divalproex sodium showing the dimeric form of valproic acid bound to sodium ions. The structure includes two valproate molecules coordinated with a sodium ion, representing the active ingredient divalproex sodium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.